Lysophosphatidic acid impairs glucose homeostasis and inhibits insulin secretion in high-fat diet obese mice

被引:0
作者
C. Rancoule
C. Attané
S. Grès
A. Fournel
R. Dusaulcy
C. Bertrand
C. Vinel
K. Tréguer
M. Prentki
P. Valet
J. S. Saulnier-Blache
机构
[1] Institut des Maladies Métaboliques et Cardiovasculaires (I2MC),Department of Nutrition
[2] Université Paul Sabaties,Department of Biochemistry
[3] Inserm U1048,undefined
[4] Molecular Nutrition Unit and Montreal Diabetes Research Center at the Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CHUM),undefined
[5] Université de Montréal,undefined
[6] Université de Montréal,undefined
来源
Diabetologia | 2013年 / 56卷
关键词
Antagonist; Glucose homeostasis; Insulin; Lysophosphatidic acid; Obesity; Receptors;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1394 / 1402
页数:8
相关论文
共 108 条
[1]  
Lee MJ(2010)Adipose tissue remodeling in pathophysiology of obesity Curr Opin Clin Nutr Metab Care 13 371-376
[2]  
Wu Y(2009)Impact of increased adipose tissue mass on inflammation, insulin resistance, and dyslipidemia Curr Diabetes Rep 9 26-32
[3]  
Fried SK(2010)The autocrine and paracrine roles of adipokines Mol Cell Endocrinol 318 69-78
[4]  
Gutierrez DA(2010)LPA receptors: subtypes and biological actions Annu Rev Pharmacol Toxicol 50 157-186
[5]  
Puglisi MJ(2009)Autotaxin Cell Mol Life Sci 66 3009-3021
[6]  
Hasty AH(2010)Autotaxin – an LPA producing enzyme with diverse functions J Biochem 148 13-24
[7]  
Karastergiou K(2008)LPA and its analogs – attractive tools for elucidation of LPA biology and drug development Curr Med Chem 15 2122-2131
[8]  
Mohamed-Ali V(2010)Pharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors Acta Pharmacol Sin 31 1213-1222
[9]  
Choi JW(2011)Lysophosphatidic acid-1-receptor targeting agents for fibrosis Expert Opin Investig Drugs 20 657-667
[10]  
Herr DR(2003)Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors Mol Pharmacol 64 994-1005